Accessible Unlicensed Requires Authentication Published by De Gruyter February 2, 2010

Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates

Guizhi Xia, Xinru Hong, Xinmin Chen, Fenghua Lan, Guocheng Zhang and Lianming Liao
From the journal


Aims: Fetal hypoxic-ischemic brain injury (HIBI) is a severe condition for which no effective therapy exists. In this study mesenchymal stem cells (MSCs) from human umbilical cord blood (UCB) of full-term newborns were isolated and intracerebrally transplanted into rat neonates after HIBI induction. Nerve function was assessed by the modified neurological severity scores (mNSS) to establish if MSCs could alleviate nerve injury.

Results: Immunostaining showed the transplanted MSCs migrated to the hippocampus. Rats receiving MSCs treatment showed significant improvement in the mNSS when compared with controls. Also, histochemical study showed alleviation of brain tissue injury after MSCs treatment. Differentiation of MSCs to astrocytes, but not neurons, was observed.

Conclusions: The results indicate a beneficial effect of intracerebral transplantation of MSCs on the functional recovery of rat neonates with HIBI.

Corresponding authors: Guocheng Zhang Department of Pediatrics Xijing Hospital The Fourth Military Medical University Xi'an 710032 China Tel.: +86-29-8477-5395 (Office) Fax: +86-29-8477-3306 Xinru Hong The Institute of Child Health of PLA Fuzhou General Hospital Fuzhou 350025 China Tel.: +86-591-2285-9200 (Office)/+86-591-8379-3257 (Home) Fax: +86-591-3812-1219

Received: 2009-3-21
Revised: 2009-8-5
Accepted: 2009-11-13
Published Online: 2010-02-02
Published Online: 2010-02-2
Published in Print: 2010-03-01

©2010 by Walter de Gruyter Berlin New York